Technical Analysis for ADPT - Adaptive Biotechnologies Corporation

Grade Last Price % Change Price Change
grade F 27.54 -4.04% -1.16
ADPT closed down 4.04 percent on Friday, October 11, 2019, on 89 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong N/A Down Down
See historical ADPT trend table...

Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
NR7 Range Contraction 0.00%
New 52 Week Low Weakness 0.00%
Wide Bands Range Expansion 0.00%
Down 3 Days in a Row Weakness 0.00%
Down 4 Days in a Row Weakness 0.00%
Oversold Stochastic Weakness 0.00%
New 52 Week Closing Low Bearish -4.04%
New Downtrend Bearish -4.04%
Wide Bands Range Expansion -4.04%

Older signals for ADPT ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Adaptive Biotechnologies Corporation develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ research service and kit that is used to answer research questions that inform current and future clinical trials, as well as to discover new prognostic and diagnostic signals. It also provides clonoSEQ diagnostic tests, which include immunosequencing services for use in the detection and monitoring of minimal residual disease in patients with select blood cancers. In addition, the company offers a pipeline of clinical products and services that are used for the diagnosing, monitoring, and treatment of diseases, such as cancer, autoimmune conditions, and infectious diseases. Adaptive Biotechnologies Corporation has strategic collaborations with Genentech, Inc. for the development, manufacture, and commercialization of neoantigen directed T cell therapies for the treatment of a range of cancers; and Microsoft Corporation to develop diagnostic tests for the early detection of various diseases from a single blood test. It serves the life sciences research, clinical diagnostics, and drug discovery customers. The company was formerly known as Adaptive TCR Corporation and changed its name to Adaptive Biotechnologies Corporation in December 2011. Adaptive Biotechnologies Corporation was founded in 2009 and is headquartered in Seattle, Washington.
Cancer Diseases Infectious Diseases Cancers Drug Discovery Diagnostic Tests Leukemia
Is ADPT a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicator Value
52 Week High 55.1203
52 Week Low 27.39
Average Volume 511,631
200-Day Moving Average 0.0
50-Day Moving Average 39.8326
20-Day Moving Average 33.8655
10-Day Moving Average 30.125
Average True Range 2.9572
ADX 25.41
+DI 15.4864
-DI 28.7772
Chandelier Exit (Long, 3 ATRs ) 35.9257
Chandelier Exit (Short, 3 ATRs ) 36.2616
Upper Bollinger Band 43.194
Lower Bollinger Band 24.537
Percent B (%b) 0.16
BandWidth 55.091465
MACD Line -3.5092
MACD Signal Line -3.1711
MACD Histogram -0.3381
Fundamentals Value
Market Cap 3.32 Billion
Num Shares 120 Million
EPS -0.15
Price-to-Earnings (P/E) Ratio -188.63
Price-to-Sales 4.89
Price-to-Book 0.91
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 30.14
Resistance 3 (R3) 30.37 29.75 29.70
Resistance 2 (R2) 29.75 29.09 29.63 29.56
Resistance 1 (R1) 28.64 28.68 28.33 28.41 29.41
Pivot Point 28.02 28.02 27.86 27.90 28.02
Support 1 (S1) 26.91 27.36 26.60 26.68 25.67
Support 2 (S2) 26.29 26.95 26.17 25.52
Support 3 (S3) 25.18 26.29 25.38
Support 4 (S4) 24.95